BioSpace News Archive

Chronic Fatigue Syndrome Therapeutics Market - R&D of New Drugs to Boost Growth Through 2019-2023 | Technavio

Technavio has announced its latest market research report titled global chronic fatigue syndrome therapeutics market 2019-2023.

November 4, 2019
·
3 min read
Genetown

Hologic Launches Definity Cervical Dilator to Provide Gentle and Seamless Dilation During Gynecologic Procedures

Physicians can now access a wide variety of uterine cavities effortlessly with innovative SureAccess balloon technology

November 4, 2019
·
4 min read
Business

Siemens Healthineers Enters into License and Supply Arrangement with Quanterix for Access to Neurofilament Light (Nf-L) Antibodies to Develop Nf-L Assays

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced it has entered into a licensing and supply arrangement with Siemens Healthineers for access to Quanterix’ proprietary Nf-L antibodies, which were recently acquired from UmanDiagnostics.

November 4, 2019
·
4 min read
Business

Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2019 Financial Results

Ripretinib Granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Patients with Advanced Gastrointestinal Stromal Tumors (GIST)

November 4, 2019
·
11 min read
Business

NanoString Technologies Releases Operating Results for Third Quarter of 2019

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, reported financial results for the third quarter of 2019.

November 4, 2019
·
12 min read
Biotech Bay

Aimmune to Participate in the Credit Suisse 28th Annual Healthcare Conference

Aimmune Therapeutics, Inc. announced that members of the Aimmune executive management team will participate in a fireside chat at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019 at 1:15 p.m. MST in Scottsdale, Arizona.

November 4, 2019
·
1 min read
Business

Teligent, Inc. Announces Third Quarter 2019 Results

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, announced its financial results for the third quarter ended September 30, 2019.

November 4, 2019
·
9 min read
Deals

Ensign Group Acquires Three Skilled Nursing Facilities in South Texas

The Ensign Group, Inc. announced that it acquired the real estate and operations of the following skilled nursing facilities in San Antonio, Texas

November 4, 2019
·
2 min read
Business

Synthetic Biologics Reports Third Quarter 2019 Operational Highlights and Financial Results

Synthetic Biologics, Inc. provided an operational update and reported financial results for the three and nine months ended September 30, 2019.

November 4, 2019
·
11 min read
Lilly to Participate in Credit Suisse 28th Annual Healthcare Conference

Eli Lilly and Company will participate in the Credit Suisse 28th Annual Healthcare Conference on Wednesday, November 13, 2019.

November 4, 2019
·
1 min read